analysis of inorganic what are the applications and impurities in
TRANSCRIPT
![Page 1: Analysis of inorganic What are the applications and impurities in](https://reader031.vdocument.in/reader031/viewer/2022020703/61fb2b662e268c58cd5af9b7/html5/thumbnails/1.jpg)
ICP-MS in pharmaceutical analysisNovember 2007
Analysis of inorganic impurities in
pharmaceuticals by ICP-MS
What are the applications and what are the benefits?
Life Sciences Solutions Unit
Katja KornetzkySolutions Manager for Process Development & Manufacturing QA/QCNovember 2007
![Page 2: Analysis of inorganic What are the applications and impurities in](https://reader031.vdocument.in/reader031/viewer/2022020703/61fb2b662e268c58cd5af9b7/html5/thumbnails/2.jpg)
ICP-MS in pharmaceutical analysisNovember 2007
Overview
• ICP-MS: The Technique
• Applications in Pharmaceutical Analysis
• The Agilent ICP-MS Compliance Software
• Conclusion
• Literature
![Page 3: Analysis of inorganic What are the applications and impurities in](https://reader031.vdocument.in/reader031/viewer/2022020703/61fb2b662e268c58cd5af9b7/html5/thumbnails/3.jpg)
ICP-MS in pharmaceutical analysisNovember 2007
What is ICP-MS?
Inductively Coupled Plasma Mass Spectrometry
Elemental analysis with:
• Wide elemental coverage• Very low detection limits• Fast analysis times (all elements at once)• Wide analytical working range (up to 9 orders)• Simple spectra• High matrix tolerance• Isotopic information
Viable alternative to ICP-OES or GFAAS*
*OES = Optical Emission Spectrometry, GFAAS = Graphite Furnace Atomic Absorption Spectrometry
![Page 4: Analysis of inorganic What are the applications and impurities in](https://reader031.vdocument.in/reader031/viewer/2022020703/61fb2b662e268c58cd5af9b7/html5/thumbnails/4.jpg)
ICP-MS in pharmaceutical analysisNovember 2007
Agilent 7500cx ICP-MS System withCollision Reaction Cell (CRC)
Low flow sample introduction system
High temperature 27MHz plasma generator
Multi-element interference removal by on-axis octopole reaction cell
High frequency hyperbolic quadrupole
Fast simultaneous dual mode detector (9 orders dynamic range)
Off-axis lens
Cell gas inlet
OctopolePlasma
![Page 5: Analysis of inorganic What are the applications and impurities in](https://reader031.vdocument.in/reader031/viewer/2022020703/61fb2b662e268c58cd5af9b7/html5/thumbnails/5.jpg)
ICP-MS in pharmaceutical analysisNovember 2007
Why is ICP-MS unique?
ICP-MS can:
• measure almost any element at ppt to ppm levels in almost any material • measure all elements in a single analysis• distinguish different element species (speciation)
Main requirements in pharmaceutical analysis are:
• high sensitivity • good matrix tolerance • low levels of interferences • ease of coupling to speciation techniques (CE, IC, LC and maybe GC)
![Page 6: Analysis of inorganic What are the applications and impurities in](https://reader031.vdocument.in/reader031/viewer/2022020703/61fb2b662e268c58cd5af9b7/html5/thumbnails/6.jpg)
ICP-MS in pharmaceutical analysisNovember 2007
Pharmaceutical applications
Pharmaceutical waste water (EPA-regulated)Drug discovery / drug development:• Analysis of individual forms of drug compounds using target element analysis • Simple metal analysis during development of metal-based drugs
QA/QC and process development:• National Pharmacopeia (e.g. USP, EP, JP) Testing
– Impurity limit tests– Metals in active pharmaceutical ingredients (API)
• QC of natural products – toxic impurities• Toxic element impurities (e.g. heavy metals)
Clinical trials:– Simple metal analysis for active component confirmation– Monitoring of the metabolites of an administered drug
![Page 7: Analysis of inorganic What are the applications and impurities in](https://reader031.vdocument.in/reader031/viewer/2022020703/61fb2b662e268c58cd5af9b7/html5/thumbnails/7.jpg)
ICP-MS in pharmaceutical analysisNovember 2007
Regulated pharmaceutical and clinical applicationsPharmacopeia Testing• Impurity limit tests (general tests or based on individual monographs)*• Quantitative metal content of API (USP monographs), e.g. Pt in platinum-containing drugs*QC of natural products• Heavy metal impurities in herbal remedies• Heavy metal contaminations in TCM** (ICP-MS in China Pharmacopeia since June 1, 2005)Metal Impurities• Catalyst or reagent residues in raw materials, pharmaceutical substances and final products
as well as packaging materials (extractables/leachables)• New EMEA draft guideline: specification limits for metal catalysts residues
Clinical Trials• Metallodrugs (e.g. Pt-containing drugs for cancer treatment)
* None of these use ICP-MS. Instead Atomic Absorption Spectrophotometry (AAS), colorimetry and gravimetry are applied.** TCM = Traditional Chinese Medicines
![Page 8: Analysis of inorganic What are the applications and impurities in](https://reader031.vdocument.in/reader031/viewer/2022020703/61fb2b662e268c58cd5af9b7/html5/thumbnails/8.jpg)
ICP-MS in pharmaceutical analysisNovember 2007
Conventional ICP-MS applications
Simple metal analysis in pharmaceuticals, raw materials and clinical samples
![Page 9: Analysis of inorganic What are the applications and impurities in](https://reader031.vdocument.in/reader031/viewer/2022020703/61fb2b662e268c58cd5af9b7/html5/thumbnails/9.jpg)
ICP-MS in pharmaceutical analysisNovember 2007
USP Methodology
• Atomic Absorption Spectroscopy– e.g. USP limit tests for <206> Al, Cr*, Rh*, Mo**
• Colorimetry– e.g. USP limit tests for <231> heavy metals, <241> Fe, <251> Pb, <211> As
• Titration– e.g. USP limit test for <261> Hg
• UV spectroscopy– e.g. USP limit tests for <291> Se, <211> As
• Gravimetry– e.g. Pt content in Cisplatin, Carboplatin (UPS monographs)
*Alprostadil monograph ** Monograph for ammonium molybdat injection
![Page 10: Analysis of inorganic What are the applications and impurities in](https://reader031.vdocument.in/reader031/viewer/2022020703/61fb2b662e268c58cd5af9b7/html5/thumbnails/10.jpg)
ICP-MS in pharmaceutical analysisNovember 2007
QC of traditional Chinese medicines (TCMs)
Chinese Pharmacopoeia 2005, Appendix IX
Agilent Application Notes:• Determination of Toxic Elements in Traditional Chinese Medicine Using Inductively
Coupled Plasma Mass Spectrometry, P/N 5989-5591EN• Evaluation of Conventional ICP-MS and ORS-ICP-MS for Analysis of Traditional
Chinese Medicines, P/N 5989-2570EN
NEW !
![Page 11: Analysis of inorganic What are the applications and impurities in](https://reader031.vdocument.in/reader031/viewer/2022020703/61fb2b662e268c58cd5af9b7/html5/thumbnails/11.jpg)
ICP-MS in pharmaceutical analysisNovember 2007
Example: Determination of heavy metalsin herbal medicines
Shugan pill exceeds legal limits for Hg (0.2 ppm) and As (2.0 ppm)[2005 Pharmacopoeia of the People’s Republic of China]
Agilent Application Note 5989-5591EN
We wish to thank Hua Zhang, Yan-zhi Shi and Ying-feng Wangat the Capital Normal University
in Beijing, China for their permission to publish the results
from their scientific study*
*Hua Zhang is a Postgraduate Student in the Chemistry Department and Yan-zhi Shi and Ying-feng Wang are Professors in the Analytical Center, all at Capital Normal University in Beijing, China.
![Page 12: Analysis of inorganic What are the applications and impurities in](https://reader031.vdocument.in/reader031/viewer/2022020703/61fb2b662e268c58cd5af9b7/html5/thumbnails/12.jpg)
ICP-MS in pharmaceutical analysisNovember 2007
Metal impurities – Leachables from pharmaceutical packaging materials1. Interaction between formulation and packaging material results in
components migrating into the drug product2. These components may be toxic or affect the stability of the drug product3. Storage conditions impact leaching (heat, UV radiation, storage time)
Typical leachables are:• Small organic molecules [monomers, excipients, reaction by-products], • Metal ions and trace elements (e.g. aluminum, cadmium, chromium, copper, lead,
manganese, and zinc)
“Metal ions can affect the stability of the formulation, catalyze the degradation of the active pharmaceutical ingredient (API) and cause unqualified degradates to form, or pose a toxicity threat on their own.”
KYLE A. FLlSZAR, DAVID WALKER and LEONARDO ALLAIN, Profiling of Metal Ions Leached from Pharmaceutical Packaging Materials, PDA Journal of Pharmaceutical Science and Technology, Vol. 60, No.6, November-December 2006
![Page 13: Analysis of inorganic What are the applications and impurities in](https://reader031.vdocument.in/reader031/viewer/2022020703/61fb2b662e268c58cd5af9b7/html5/thumbnails/13.jpg)
ICP-MS in pharmaceutical analysisNovember 2007
Guideline on the specification limits for residues of metal catalysts
EMEA* draft guideline dated January 2007
Objective:“Recommend maximum acceptable metal residues arising from the use of metals
as catalysts or reagents in the synthesis of drug substances and excipients.”
Since the use of catalysts or reagents is restricted to defined chemical reactions in the synthesis of pharmaceutical substances, limitation of residues in these substances is sufficient, and in general there is no need to set limits for metal residues in the final medicinal products containing these substances.
* European MEdicinal Agency: Its main responsibility is the protection and promotion of public and animal health, through the evaluation and supervision of medicines for human and veterinary use. The EMEA is responsible for the scientific evaluation of applications for European marketing authorization for medicinal products
![Page 14: Analysis of inorganic What are the applications and impurities in](https://reader031.vdocument.in/reader031/viewer/2022020703/61fb2b662e268c58cd5af9b7/html5/thumbnails/14.jpg)
ICP-MS in pharmaceutical analysisNovember 2007
Metal catalyst residues EMEA classification and concentration limits
![Page 15: Analysis of inorganic What are the applications and impurities in](https://reader031.vdocument.in/reader031/viewer/2022020703/61fb2b662e268c58cd5af9b7/html5/thumbnails/15.jpg)
ICP-MS in pharmaceutical analysisNovember 2007
ICP-MS for routine analysis in drug discovery & clinical trials
Clinical samples require
• High sensitivity (measurement of low-level trace elements)
• Excellent matrix tolerance (biological matrices)
• Large number of samples analyzed daily
Matrix tolerance is an essential part of clinical analysis
• High potential for matrix contamination of the ICP-MS system, if the matrix is not effectively decomposed
• Resulting deposits may adversely affect instrument performance
• Efficiency of plasma determines matrix tolerance
![Page 16: Analysis of inorganic What are the applications and impurities in](https://reader031.vdocument.in/reader031/viewer/2022020703/61fb2b662e268c58cd5af9b7/html5/thumbnails/16.jpg)
ICP-MS in pharmaceutical analysisNovember 2007
Example 1: sanofi-aventis (UK)High throughput assay for oxaliplatin
Success StoryPub. No.
5989-7077EN
Increased sample throughput and improved reliability
with an Agilent 7500a ICP-MS
“An Agilent 7500 ICP-MS instrument was chosen as the replacement equipment because of the excellent matrix tolerance, lower backgrounds, larger dynamic range and smaller footprint.”
![Page 17: Analysis of inorganic What are the applications and impurities in](https://reader031.vdocument.in/reader031/viewer/2022020703/61fb2b662e268c58cd5af9b7/html5/thumbnails/17.jpg)
ICP-MS in pharmaceutical analysisNovember 2007
Example 2: Long-term sample analysisMatrix tolerance is of major importance
An efficient plasma design:
• reduces matrix load on the interface and vacuum system (less signal drift)
• reduce the maintenance
• increases ionisation efficiency of key trace elements, e.g. Zn, Cd and Hg
• removes interferences by efficient decomposition of matrix-based polyatomic species
Isla Strang and Alan Cox with 2 Agilent 4500 ICP-MS systems.Courtesy of Centre for Analytical Sciences, Sheffield
![Page 18: Analysis of inorganic What are the applications and impurities in](https://reader031.vdocument.in/reader031/viewer/2022020703/61fb2b662e268c58cd5af9b7/html5/thumbnails/18.jpg)
ICP-MS in pharmaceutical analysisNovember 2007
Advanced ICP-MS applications – speciation
ICP-MS as a sensitive detector with high specificity for established separation techniques
![Page 19: Analysis of inorganic What are the applications and impurities in](https://reader031.vdocument.in/reader031/viewer/2022020703/61fb2b662e268c58cd5af9b7/html5/thumbnails/19.jpg)
ICP-MS in pharmaceutical analysisNovember 2007
What is speciation?
*J. A. Caruso, K. L. Sutton, and K. L. Ackley, ”Elemental Speciation - New Approaches for Trace Element Analysis,”Chap. 1, p. 1, Volume XXXIII of COMPREHENSIVE ANALYTICAL CHEMISTRY. Elsevier Publishing, Netherlands, 2000.
“Elemental Speciation - the analyses that lead to determining the distribution of an element’s particular chemical species in a sample. This may be further associated with oxidation state, organometallic nature or complex form.”*
![Page 20: Analysis of inorganic What are the applications and impurities in](https://reader031.vdocument.in/reader031/viewer/2022020703/61fb2b662e268c58cd5af9b7/html5/thumbnails/20.jpg)
ICP-MS in pharmaceutical analysisNovember 2007
Why do we need speciation?
Almost all elements form species which can alter their toxicity and mobility
• CrIII vs CrVI; inorganic As vs organic As; humic acid complexes …
Some species vary in toxicity or therapeutic activity
• Pt-containing drugs in cancer treatment – Anti-tumour activity versus side effects of drugs and metabolites
– Species with different structure and Pt oxidation state
• Medical research on capability of proteins in binding different (toxic) metals– Metallothionein isoforms
• Heavy metal or pesticide impurities in natural products– For example, organomercury or organophosphorus species
• Speciation of heteroatom-containing drugs (e.g. Cl, Br, S, P)
Need simple, selective, rapid, sensitive and accurate determination of these species
![Page 21: Analysis of inorganic What are the applications and impurities in](https://reader031.vdocument.in/reader031/viewer/2022020703/61fb2b662e268c58cd5af9b7/html5/thumbnails/21.jpg)
ICP-MS in pharmaceutical analysisNovember 2007
Practical coupled techniques for ICP-MS
ICP-MS is suitable for coupling to many separation methods:
• Capillary Electrophoresis (CE)
• Ion Chromatography (IC)
• Liquid Chromatography (HPLC)
• Gas Chromatography (GC)
![Page 22: Analysis of inorganic What are the applications and impurities in](https://reader031.vdocument.in/reader031/viewer/2022020703/61fb2b662e268c58cd5af9b7/html5/thumbnails/22.jpg)
ICP-MS in pharmaceutical analysisNovember 2007
Suitability of ICP-MS for chromatography
• Suitable for liquid or gas phase
• Usable with a wide range of flow rates– Liquid phase: less than 20µL/min (capillary LC) to 2mL/min (standard LC)
• Less than 1uL/min flow (e.g. nano-LC or CE) can be handled, with a make-up solution
– Gas phase: Conventional GC carrier gas flow rates can be used, with a make-up Ar flow (~1L/min)
• Tolerates a variety of LC mobile phases– Organic solvents, gradients from aqueous to organic
– High salt buffers
• High sensitivity for most elements
• Rapid data acquisition – sufficient # of data points across chromatographic peak
• Ability to measure isotopes (isotope tracer studies, isotope dilution calibration)
• Mass selective and extremely specific – mass spectrum almost free from inter-element effects – isotopes of all elements are free from direct
overlap from another element
![Page 23: Analysis of inorganic What are the applications and impurities in](https://reader031.vdocument.in/reader031/viewer/2022020703/61fb2b662e268c58cd5af9b7/html5/thumbnails/23.jpg)
ICP-MS in pharmaceutical analysisNovember 2007
CE interface for ICP-MS
Photo courtesy of Dr Andreas Prange, GKSS, Germany
Instrumentation:• Agilent 3D CE• Cetac CEI-100 interface• Agilent 7500s ICP-MS
![Page 24: Analysis of inorganic What are the applications and impurities in](https://reader031.vdocument.in/reader031/viewer/2022020703/61fb2b662e268c58cd5af9b7/html5/thumbnails/24.jpg)
ICP-MS in pharmaceutical analysisNovember 2007
CE interface for ICP-MS
CE interface requires• make-up liquid flow to carry eluent to ICP-MS nebulizer
• very low flow nebulizer and low-volume spray chamber for efficient aerosol transport and preservation of chromatographic separation
Photo courtesy of Dr Andreas Prange, GKSS, Germany
![Page 25: Analysis of inorganic What are the applications and impurities in](https://reader031.vdocument.in/reader031/viewer/2022020703/61fb2b662e268c58cd5af9b7/html5/thumbnails/25.jpg)
ICP-MS in pharmaceutical analysisNovember 2007
Speciation in medical research CE-ICP-MS for separation of metallothioneins (MT)
Metallothioneins are
• A group of proteins • Capable of binding physiological and
xenobiotic heavy metals
– CE preserves the molecular structure of high molecular weight (MW) compounds
– speciation of high MW molecules, such as metallothionein isoforms
Courtesy of Dr Andreas Prange, GKSS, Germany
CE-ICP-MS is suitable forthe rapid speciation of elemental species
![Page 26: Analysis of inorganic What are the applications and impurities in](https://reader031.vdocument.in/reader031/viewer/2022020703/61fb2b662e268c58cd5af9b7/html5/thumbnails/26.jpg)
ICP-MS in pharmaceutical analysisNovember 2007
Speciation in medical research CE-ICP-MS analysis of MT in brain tissue
Courtesy of Dr Andreas Prange, GKSS, Germany
![Page 27: Analysis of inorganic What are the applications and impurities in](https://reader031.vdocument.in/reader031/viewer/2022020703/61fb2b662e268c58cd5af9b7/html5/thumbnails/27.jpg)
ICP-MS in pharmaceutical analysisNovember 2007
LC-ICP-MS – first hyphenated technique to be seriously investigated
nebulizer &spraychamber
gas controller
ICP torch
turbomolecularpump
Q-pole mass filter
Ar gas
rotary pump
turbomolecularpump
liquid chromatograph
The Agilent 1100 LC coupling provides • Integrated sequencing for routine analysis
• Use of organic mobile phases
Agilent 1100 LC coupled directly or via
split to 7500 ICP-MS
![Page 28: Analysis of inorganic What are the applications and impurities in](https://reader031.vdocument.in/reader031/viewer/2022020703/61fb2b662e268c58cd5af9b7/html5/thumbnails/28.jpg)
ICP-MS in pharmaceutical analysisNovember 2007
11.2011.4011.6011.8012.0012.2012.4012.6012.8013.0013.2013.4013.600
10000
20000
30000
40000
50000
60000
70000
80000
90000
100000
110000
120000
130000
140000
150000
160000
170000
180000
Time-->
Abundance
Ion 79.00 (78.70 to 79.70): 000_STD.DIon 79.00 (78.70 to 79.70): 002_STD.DIon 79.00 (78.70 to 79.70): 003_STD.DIon 79.00 (78.70 to 79.70): 004SMPL.DIon 79.00 (78.70 to 79.70): 005SMPL.DIon 79.00 (78.70 to 79.70): 006SMPL.DIon 79.00 (78.70 to 79.70): 007SMPL.D
Standards: 0.0, 0.02, 0.05, 0.1mg
Samples (3 replicates):
• 1.0 mg of Cl compound 1
• 0.1 mg of all other compounds
2.00 4.00 6.00 8.00 10.00 12.00 14.00 16.000
10000
20000
30000
40000
50000
60000
70000
80000
90000
100000
110000
120000
130000
140000
150000
160000
170000
180000
190000
Time-->
Abundance
Ion 35.00 (34.70 to 35.70): 000_STD.DIon 35.00 (34.70 to 35.70): 002_STD.DIon 35.00 (34.70 to 35.70): 003_STD.DIon 35.00 (34.70 to 35.70): 004SMPL.DIon 35.00 (34.70 to 35.70): 005SMPL.DIon 35.00 (34.70 to 35.70): 006SMPL.DIon 35.00 (34.70 to 35.70): 007SMPL.D
Data courtesy of Martin Gray, Sanofi-Synthelabo
Speciation for pharmaceutical samplesDetermination of Cl, Br & S heteroatoms
Separation and quantification of 3 Cl compounds (left)
and 1 Br compound (right) in a mixed sample
35Cl 79Br
![Page 29: Analysis of inorganic What are the applications and impurities in](https://reader031.vdocument.in/reader031/viewer/2022020703/61fb2b662e268c58cd5af9b7/html5/thumbnails/29.jpg)
ICP-MS in pharmaceutical analysisNovember 2007
Speciation in clinical research Pt compounds in anti-tumor drugs
Data courtesy of Peter Galettis, University of Auckland, New Zealand
![Page 30: Analysis of inorganic What are the applications and impurities in](https://reader031.vdocument.in/reader031/viewer/2022020703/61fb2b662e268c58cd5af9b7/html5/thumbnails/30.jpg)
ICP-MS in pharmaceutical analysisNovember 2007
Speciation in clinical research Pt compounds in anti-tumor drugs
What is Cisplatin? • An anti-neoplastic drug with proven effectiveness against cancer• One of the most important anti-tumor drugs in clinical oncology
But there are some side effects:• For example nephrotoxicity and nausea, • Some result from the activity of metabolite products from the administered drug
As a result:• search for second generation platinum compounds with less nephrotoxicity and greater anti-
tumor activity. • To investigate the behavior of platinum compounds, a selective and sensitive analytical
method is required.
LC-ICP-MS is ideal for this application.
Peter Galettis, University of Auckland, New Zealand
![Page 31: Analysis of inorganic What are the applications and impurities in](https://reader031.vdocument.in/reader031/viewer/2022020703/61fb2b662e268c58cd5af9b7/html5/thumbnails/31.jpg)
ICP-MS in pharmaceutical analysisNovember 2007
Speciation in clinical research Example: Pt species in compound JM216
Data courtesy of Peter Galettis, University of Auckland, New Zealand
Chromatogram for 2.29 mg/L of the main compound JM216 [Bis (acetato) amine-dichloro (cyclohexylamine) platinum (IV)], Agilent application P/N 5968-8185E
The combination of HPLC with ICP-MS detection enables the determination of Pt compound impurities down to ng levels.
JM216
JM216
JM216
ICP-MS provides the sensitivity and specificity to analyze trace level of Platinum compounds with highest throughput.
![Page 32: Analysis of inorganic What are the applications and impurities in](https://reader031.vdocument.in/reader031/viewer/2022020703/61fb2b662e268c58cd5af9b7/html5/thumbnails/32.jpg)
ICP-MS in pharmaceutical analysisNovember 2007
Advanced ICP-MS applications – speciation
Combined elemental and organic spectrometry
1) ICP-MS combined with UV detection (conventional LC detector with flow-through cell)
2) ICP-MS combined with molecular mass spectrometry to give elemental detection and quantification, as well as molecular structure and compound identification
![Page 33: Analysis of inorganic What are the applications and impurities in](https://reader031.vdocument.in/reader031/viewer/2022020703/61fb2b662e268c58cd5af9b7/html5/thumbnails/33.jpg)
ICP-MS in pharmaceutical analysisNovember 2007
Laser Ablation ICP-MS Analysis of solid sample surfaces
Merchantek UP 213 Laser Ablation System linked to Agilent 7500 ICP-MS
![Page 34: Analysis of inorganic What are the applications and impurities in](https://reader031.vdocument.in/reader031/viewer/2022020703/61fb2b662e268c58cd5af9b7/html5/thumbnails/34.jpg)
ICP-MS in pharmaceutical analysisNovember 2007
Principles of laser ablation (LA) ICP-MS
LASER - Light Amplification by Stimulated Emission of Radiation
Procedure:
• Laser beam focused onto sample surface in ablation chamber or cell
• Miniature plasma above sample ablates material from surface
• Resultant particulate material is transported to ICP-MS with carrier gas stream (e.g. Ar)
• Sample is decomposed, atomised and ionized in ICP plasma and analyzed in mass spectrometer
Applications for LA-ICP-MS:
• Monitor distribution of administered drugs among different tissues and body compartments
• In-situ analysis of metals and other elements in samples separated using PAGE*, e.g.:
– Au and Pt drug metabolite identification
– Determine degree of phosphorylation of different separated proteins
* Polyacrylamide gel electrophoresis
![Page 35: Analysis of inorganic What are the applications and impurities in](https://reader031.vdocument.in/reader031/viewer/2022020703/61fb2b662e268c58cd5af9b7/html5/thumbnails/35.jpg)
ICP-MS in pharmaceutical analysisNovember 2007
In-situ direct tissue analysis Example: Analysis of brain tissue (rat)
Brain tissue –the laser sampling pattern can be seen on the rat brain tissue sample
Courtesy of Centre for Analytical Sciences, Sheffield
After administration of the drug, the test animal is freeze-dried, encased in polymer and microtomed. Individual sections are then analyzed using laser ablation.
![Page 36: Analysis of inorganic What are the applications and impurities in](https://reader031.vdocument.in/reader031/viewer/2022020703/61fb2b662e268c58cd5af9b7/html5/thumbnails/36.jpg)
ICP-MS in pharmaceutical analysisNovember 2007
Example: Element distribution in rat brain sample after drug treatment
Distribution of different elements in tissue sections Elements shown are Mg, Fe and P
Courtesy of Centre for Analytical Sciences, Sheffield
31P
26Mg Fe
![Page 37: Analysis of inorganic What are the applications and impurities in](https://reader031.vdocument.in/reader031/viewer/2022020703/61fb2b662e268c58cd5af9b7/html5/thumbnails/37.jpg)
ICP-MS in pharmaceutical analysisNovember 2007
Use of ICP-MS in regulated environmentsComplying with 21 CFR Part 11Agilent’s solution for ICP-MS ensures…
… data security by:
• Secure central storage of data
• User access limited to authorized individuals
… data integrity by:
• Automatic data storage and versioning
• Full version control for ALL relevant data including original result reports
• Integrated archival and long-term storage in a content management system
… data traceability by:
• Automatic user-independent audit trail
• Electronic signatures
Full support of all requirements mandated
by 21 CFR Part 11 in closed system
![Page 38: Analysis of inorganic What are the applications and impurities in](https://reader031.vdocument.in/reader031/viewer/2022020703/61fb2b662e268c58cd5af9b7/html5/thumbnails/38.jpg)
ICP-MS in pharmaceutical analysisNovember 2007
Complying with 21 CFR Part 11More details
“Agilent ICP-MS ChemStation –Complying with 21 CFR Part 11”
Agilent Application Note
Publication number: 5989-4850EN
http://www.chem.agilent.com/scripts/LiteraturePDF.asp?iWHID=45817
![Page 39: Analysis of inorganic What are the applications and impurities in](https://reader031.vdocument.in/reader031/viewer/2022020703/61fb2b662e268c58cd5af9b7/html5/thumbnails/39.jpg)
ICP-MS in pharmaceutical analysisNovember 2007
Use of ICP-MS in regulated environments Boosting productivity
Agilent’s solution for ICP-MS adds value by…
…fully supporting your workflow with:
• Data review independent of ICP-MS ChemStation
• Extensive search and retrieve capabilities
• Data access from anywhere using a web browser
• One central repository for all your data and related documents (e.g. SOP documents, electronic reports, spreadsheets, …)
… and enabling easy administration with:
• Standard Windows user administration
• Scalable solution – from single instrument to enterprise system
• Integrated data archival
![Page 40: Analysis of inorganic What are the applications and impurities in](https://reader031.vdocument.in/reader031/viewer/2022020703/61fb2b662e268c58cd5af9b7/html5/thumbnails/40.jpg)
ICP-MS in pharmaceutical analysisNovember 2007
Literature
• High Throughput Assay for Oxaliplation: P/N 5989-7077EN
• Determination of Toxic Elements in Traditional Chinese Medicine Using Inductively Coupled Plasma Mass Spectrometry, P/N 5989-5591EN
• Evaluation of Conventional ICP-MS and ORS-ICP-MS for Analysis of Traditional Chinese Medicines, P/N 5989-2570EN
• Agilent ICP-MS Journal # 32: Including article on compliant ICP-MS
• Handbook of Hyphenated ICP-MS Techniques